Report Detail

Service & Software Global Small Molecule API Development Service Market Growth (Status and Outlook) 2022-2028

  • RnM4468140
  • |
  • 18 July, 2022
  • |
  • Global
  • |
  • 121 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

As the global economy mends, the 2021 growth of Small Molecule API Development Service will have significant change from previous year. According to our (LP Information) latest study, the global Small Molecule API Development Service market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Small Molecule API Development Service market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Small Molecule API Development Service market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Small Molecule API Development Service market, reaching US$ million by the year 2028. As for the Europe Small Molecule API Development Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Small Molecule API Development Service players cover Thermo Fisher Scientific Patheon, Eurofins, CordenPharma, and pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule API Development Service market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Chemical API
Biological API

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pharmaceutical Factory
Research Institutions
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific Patheon
Eurofins
CordenPharma
pfizer
BOC Science
Recipharm
Cambrex
Aji Bio-Pharma
Lonza
Asymchem
Catalent
Esteve
Evonik
PCI
Syngene
Almac
Sterling
Onyx Scientific
Regis Technologies
Novasep
ChemPartner
Pharmaron
STA Pharmaceutical
Solvias
Aurigene
WuXi AppTec
Merck Millipore
Minakem
Woodstock Sterile Solutions
ICON plc
BioVectra
Lysis Pharma
Ash Stevens


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Small Molecule API Development Service Market Size 2017-2028
    • 2.1.2 Small Molecule API Development Service Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Small Molecule API Development Service Segment by Type
    • 2.2.1 Chemical API
    • 2.2.2 Biological API
  • 2.3 Small Molecule API Development Service Market Size by Type
    • 2.3.1 Small Molecule API Development Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Small Molecule API Development Service Market Size Market Share by Type (2017-2022)
  • 2.4 Small Molecule API Development Service Segment by Application
    • 2.4.1 Pharmaceutical Factory
    • 2.4.2 Research Institutions
    • 2.4.3 Others
  • 2.5 Small Molecule API Development Service Market Size by Application
    • 2.5.1 Small Molecule API Development Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Small Molecule API Development Service Market Size Market Share by Application (2017-2022)

3 Small Molecule API Development Service Market Size by Player

  • 3.1 Small Molecule API Development Service Market Size Market Share by Players
    • 3.1.1 Global Small Molecule API Development Service Revenue by Players (2020-2022)
    • 3.1.2 Global Small Molecule API Development Service Revenue Market Share by Players (2020-2022)
  • 3.2 Global Small Molecule API Development Service Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Small Molecule API Development Service by Regions

  • 4.1 Small Molecule API Development Service Market Size by Regions (2017-2022)
  • 4.2 Americas Small Molecule API Development Service Market Size Growth (2017-2022)
  • 4.3 APAC Small Molecule API Development Service Market Size Growth (2017-2022)
  • 4.4 Europe Small Molecule API Development Service Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Small Molecule API Development Service Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Small Molecule API Development Service Market Size by Country (2017-2022)
  • 5.2 Americas Small Molecule API Development Service Market Size by Type (2017-2022)
  • 5.3 Americas Small Molecule API Development Service Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Small Molecule API Development Service Market Size by Region (2017-2022)
  • 6.2 APAC Small Molecule API Development Service Market Size by Type (2017-2022)
  • 6.3 APAC Small Molecule API Development Service Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Small Molecule API Development Service by Country (2017-2022)
  • 7.2 Europe Small Molecule API Development Service Market Size by Type (2017-2022)
  • 7.3 Europe Small Molecule API Development Service Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Small Molecule API Development Service by Region (2017-2022)
  • 8.2 Middle East & Africa Small Molecule API Development Service Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Small Molecule API Development Service Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Small Molecule API Development Service Market Forecast

  • 10.1 Global Small Molecule API Development Service Forecast by Regions (2023-2028)
    • 10.1.1 Global Small Molecule API Development Service Forecast by Regions (2023-2028)
    • 10.1.2 Americas Small Molecule API Development Service Forecast
    • 10.1.3 APAC Small Molecule API Development Service Forecast
    • 10.1.4 Europe Small Molecule API Development Service Forecast
    • 10.1.5 Middle East & Africa Small Molecule API Development Service Forecast
  • 10.2 Americas Small Molecule API Development Service Forecast by Country (2023-2028)
    • 10.2.1 United States Small Molecule API Development Service Market Forecast
    • 10.2.2 Canada Small Molecule API Development Service Market Forecast
    • 10.2.3 Mexico Small Molecule API Development Service Market Forecast
    • 10.2.4 Brazil Small Molecule API Development Service Market Forecast
  • 10.3 APAC Small Molecule API Development Service Forecast by Region (2023-2028)
    • 10.3.1 China Small Molecule API Development Service Market Forecast
    • 10.3.2 Japan Small Molecule API Development Service Market Forecast
    • 10.3.3 Korea Small Molecule API Development Service Market Forecast
    • 10.3.4 Southeast Asia Small Molecule API Development Service Market Forecast
    • 10.3.5 India Small Molecule API Development Service Market Forecast
    • 10.3.6 Australia Small Molecule API Development Service Market Forecast
  • 10.4 Europe Small Molecule API Development Service Forecast by Country (2023-2028)
    • 10.4.1 Germany Small Molecule API Development Service Market Forecast
    • 10.4.2 France Small Molecule API Development Service Market Forecast
    • 10.4.3 UK Small Molecule API Development Service Market Forecast
    • 10.4.4 Italy Small Molecule API Development Service Market Forecast
    • 10.4.5 Russia Small Molecule API Development Service Market Forecast
  • 10.5 Middle East & Africa Small Molecule API Development Service Forecast by Region (2023-2028)
    • 10.5.1 Egypt Small Molecule API Development Service Market Forecast
    • 10.5.2 South Africa Small Molecule API Development Service Market Forecast
    • 10.5.3 Israel Small Molecule API Development Service Market Forecast
    • 10.5.4 Turkey Small Molecule API Development Service Market Forecast
    • 10.5.5 GCC Countries Small Molecule API Development Service Market Forecast
  • 10.6 Global Small Molecule API Development Service Forecast by Type (2023-2028)
  • 10.7 Global Small Molecule API Development Service Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific Patheon
    • 11.1.1 Thermo Fisher Scientific Patheon Company Information
    • 11.1.2 Thermo Fisher Scientific Patheon Small Molecule API Development Service Product Offered
    • 11.1.3 Thermo Fisher Scientific Patheon Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Thermo Fisher Scientific Patheon Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Patheon Latest Developments
  • 11.2 Eurofins
    • 11.2.1 Eurofins Company Information
    • 11.2.2 Eurofins Small Molecule API Development Service Product Offered
    • 11.2.3 Eurofins Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Eurofins Main Business Overview
    • 11.2.5 Eurofins Latest Developments
  • 11.3 CordenPharma
    • 11.3.1 CordenPharma Company Information
    • 11.3.2 CordenPharma Small Molecule API Development Service Product Offered
    • 11.3.3 CordenPharma Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 CordenPharma Main Business Overview
    • 11.3.5 CordenPharma Latest Developments
  • 11.4 pfizer
    • 11.4.1 pfizer Company Information
    • 11.4.2 pfizer Small Molecule API Development Service Product Offered
    • 11.4.3 pfizer Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 pfizer Main Business Overview
    • 11.4.5 pfizer Latest Developments
  • 11.5 BOC Science
    • 11.5.1 BOC Science Company Information
    • 11.5.2 BOC Science Small Molecule API Development Service Product Offered
    • 11.5.3 BOC Science Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 BOC Science Main Business Overview
    • 11.5.5 BOC Science Latest Developments
  • 11.6 Recipharm
    • 11.6.1 Recipharm Company Information
    • 11.6.2 Recipharm Small Molecule API Development Service Product Offered
    • 11.6.3 Recipharm Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Recipharm Main Business Overview
    • 11.6.5 Recipharm Latest Developments
  • 11.7 Cambrex
    • 11.7.1 Cambrex Company Information
    • 11.7.2 Cambrex Small Molecule API Development Service Product Offered
    • 11.7.3 Cambrex Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Cambrex Main Business Overview
    • 11.7.5 Cambrex Latest Developments
  • 11.8 Aji Bio-Pharma
    • 11.8.1 Aji Bio-Pharma Company Information
    • 11.8.2 Aji Bio-Pharma Small Molecule API Development Service Product Offered
    • 11.8.3 Aji Bio-Pharma Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Aji Bio-Pharma Main Business Overview
    • 11.8.5 Aji Bio-Pharma Latest Developments
  • 11.9 Lonza
    • 11.9.1 Lonza Company Information
    • 11.9.2 Lonza Small Molecule API Development Service Product Offered
    • 11.9.3 Lonza Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Lonza Main Business Overview
    • 11.9.5 Lonza Latest Developments
  • 11.10 Asymchem
    • 11.10.1 Asymchem Company Information
    • 11.10.2 Asymchem Small Molecule API Development Service Product Offered
    • 11.10.3 Asymchem Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Asymchem Main Business Overview
    • 11.10.5 Asymchem Latest Developments
  • 11.11 Catalent
    • 11.11.1 Catalent Company Information
    • 11.11.2 Catalent Small Molecule API Development Service Product Offered
    • 11.11.3 Catalent Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Catalent Main Business Overview
    • 11.11.5 Catalent Latest Developments
  • 11.12 Esteve
    • 11.12.1 Esteve Company Information
    • 11.12.2 Esteve Small Molecule API Development Service Product Offered
    • 11.12.3 Esteve Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Esteve Main Business Overview
    • 11.12.5 Esteve Latest Developments
  • 11.13 Evonik
    • 11.13.1 Evonik Company Information
    • 11.13.2 Evonik Small Molecule API Development Service Product Offered
    • 11.13.3 Evonik Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Evonik Main Business Overview
    • 11.13.5 Evonik Latest Developments
  • 11.14 PCI
    • 11.14.1 PCI Company Information
    • 11.14.2 PCI Small Molecule API Development Service Product Offered
    • 11.14.3 PCI Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 PCI Main Business Overview
    • 11.14.5 PCI Latest Developments
  • 11.15 Syngene
    • 11.15.1 Syngene Company Information
    • 11.15.2 Syngene Small Molecule API Development Service Product Offered
    • 11.15.3 Syngene Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Syngene Main Business Overview
    • 11.15.5 Syngene Latest Developments
  • 11.16 Almac
    • 11.16.1 Almac Company Information
    • 11.16.2 Almac Small Molecule API Development Service Product Offered
    • 11.16.3 Almac Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Almac Main Business Overview
    • 11.16.5 Almac Latest Developments
  • 11.17 Sterling
    • 11.17.1 Sterling Company Information
    • 11.17.2 Sterling Small Molecule API Development Service Product Offered
    • 11.17.3 Sterling Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Sterling Main Business Overview
    • 11.17.5 Sterling Latest Developments
  • 11.18 Onyx Scientific
    • 11.18.1 Onyx Scientific Company Information
    • 11.18.2 Onyx Scientific Small Molecule API Development Service Product Offered
    • 11.18.3 Onyx Scientific Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Onyx Scientific Main Business Overview
    • 11.18.5 Onyx Scientific Latest Developments
  • 11.19 Regis Technologies
    • 11.19.1 Regis Technologies Company Information
    • 11.19.2 Regis Technologies Small Molecule API Development Service Product Offered
    • 11.19.3 Regis Technologies Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 Regis Technologies Main Business Overview
    • 11.19.5 Regis Technologies Latest Developments
  • 11.20 Novasep
    • 11.20.1 Novasep Company Information
    • 11.20.2 Novasep Small Molecule API Development Service Product Offered
    • 11.20.3 Novasep Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 Novasep Main Business Overview
    • 11.20.5 Novasep Latest Developments
  • 11.21 ChemPartner
    • 11.21.1 ChemPartner Company Information
    • 11.21.2 ChemPartner Small Molecule API Development Service Product Offered
    • 11.21.3 ChemPartner Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.21.4 ChemPartner Main Business Overview
    • 11.21.5 ChemPartner Latest Developments
  • 11.22 Pharmaron
    • 11.22.1 Pharmaron Company Information
    • 11.22.2 Pharmaron Small Molecule API Development Service Product Offered
    • 11.22.3 Pharmaron Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.22.4 Pharmaron Main Business Overview
    • 11.22.5 Pharmaron Latest Developments
  • 11.23 STA Pharmaceutical
    • 11.23.1 STA Pharmaceutical Company Information
    • 11.23.2 STA Pharmaceutical Small Molecule API Development Service Product Offered
    • 11.23.3 STA Pharmaceutical Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.23.4 STA Pharmaceutical Main Business Overview
    • 11.23.5 STA Pharmaceutical Latest Developments
  • 11.24 Solvias
    • 11.24.1 Solvias Company Information
    • 11.24.2 Solvias Small Molecule API Development Service Product Offered
    • 11.24.3 Solvias Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.24.4 Solvias Main Business Overview
    • 11.24.5 Solvias Latest Developments
  • 11.25 Aurigene
    • 11.25.1 Aurigene Company Information
    • 11.25.2 Aurigene Small Molecule API Development Service Product Offered
    • 11.25.3 Aurigene Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.25.4 Aurigene Main Business Overview
    • 11.25.5 Aurigene Latest Developments
  • 11.26 WuXi AppTec
    • 11.26.1 WuXi AppTec Company Information
    • 11.26.2 WuXi AppTec Small Molecule API Development Service Product Offered
    • 11.26.3 WuXi AppTec Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.26.4 WuXi AppTec Main Business Overview
    • 11.26.5 WuXi AppTec Latest Developments
  • 11.27 Merck Millipore
    • 11.27.1 Merck Millipore Company Information
    • 11.27.2 Merck Millipore Small Molecule API Development Service Product Offered
    • 11.27.3 Merck Millipore Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.27.4 Merck Millipore Main Business Overview
    • 11.27.5 Merck Millipore Latest Developments
  • 11.28 Minakem
    • 11.28.1 Minakem Company Information
    • 11.28.2 Minakem Small Molecule API Development Service Product Offered
    • 11.28.3 Minakem Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.28.4 Minakem Main Business Overview
    • 11.28.5 Minakem Latest Developments
  • 11.29 Woodstock Sterile Solutions
    • 11.29.1 Woodstock Sterile Solutions Company Information
    • 11.29.2 Woodstock Sterile Solutions Small Molecule API Development Service Product Offered
    • 11.29.3 Woodstock Sterile Solutions Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.29.4 Woodstock Sterile Solutions Main Business Overview
    • 11.29.5 Woodstock Sterile Solutions Latest Developments
  • 11.30 ICON plc
    • 11.30.1 ICON plc Company Information
    • 11.30.2 ICON plc Small Molecule API Development Service Product Offered
    • 11.30.3 ICON plc Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.30.4 ICON plc Main Business Overview
    • 11.30.5 ICON plc Latest Developments
  • 11.31 BioVectra
    • 11.31.1 BioVectra Company Information
    • 11.31.2 BioVectra Small Molecule API Development Service Product Offered
    • 11.31.3 BioVectra Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.31.4 BioVectra Main Business Overview
    • 11.31.5 BioVectra Latest Developments
  • 11.32 Lysis Pharma
    • 11.32.1 Lysis Pharma Company Information
    • 11.32.2 Lysis Pharma Small Molecule API Development Service Product Offered
    • 11.32.3 Lysis Pharma Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.32.4 Lysis Pharma Main Business Overview
    • 11.32.5 Lysis Pharma Latest Developments
  • 11.33 Ash Stevens
    • 11.33.1 Ash Stevens Company Information
    • 11.33.2 Ash Stevens Small Molecule API Development Service Product Offered
    • 11.33.3 Ash Stevens Small Molecule API Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.33.4 Ash Stevens Main Business Overview
    • 11.33.5 Ash Stevens Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Small Molecule API Development Service. Industry analysis & Market Report on Small Molecule API Development Service is a syndicated market report, published as Global Small Molecule API Development Service Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Small Molecule API Development Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report